Commodore Capital’s Entera Bio ENTX Stock Holding History
Bought
Maintained
Sold
Other funds holding ENTX
SFCM
SL
KCM
Commodore Capital's ENTX Position: Q3 2026 in Review
Commodore Capital opened a new position in Entera Bio (ENTX) in Q3 2026: 7,352,941 shares worth $21.4M. The stake represents 1.66% of the portfolio and ranks #19 among its holdings.
45 funds tracked by Wall St. Rank hold ENTX as of Q3 2026.
- Commodore Capital held 7,352,941 shares of Entera Bio worth $21.4M as of Q3 2026.
- Entera Bio was a new Commodore Capital position in Q3 2026.
- Entera Bio made up 1.66% of Commodore Capital's portfolio in Q3 2026, its #19 holding.
- 45 funds tracked by Wall St. Rank held Entera Bio as of Q3 2026.
Based on Commodore Capital's 13F filing for Q3 2026, filed 16 Nov 2026.